诱导性多潜能干细胞在心肌再生方面的潜在应用

doi:10.3969/j.issn.1674-490X.2011.06.014

摘要/Abstract

摘要： 心血管病严重威胁着人类健康.对症治疗只能暂时缓解症状,延缓疾病进展,不能从根本上解决问题.诱导性多潜能干细胞(iPS cell)是近年生命科学领域的突破性研究成果.该类细胞具有增殖及多向分化潜能,形态及功能类似胚胎干细胞而又优于胚胎干细胞,可在特定诱导条件下转化为心肌细胞.通过iPS细胞移植实现心肌修复与再生可为心血管患者带来新的希望.

中图分类号:

李志军,曹雪滨. 诱导性多潜能干细胞在心肌再生方面的潜在应用[J]. 医学研究与教育, 2011, 28(6): 54-57,71.

LI Zhijun,CAO Xuebin. The potential applications of iPS cells in repairing and regenerating infarcted myocardium[J]. Medical Reserch and Education, 2011, 28(6): 54-57,71.

[1] Caspi, O, Huber, I, Kehat, I, Habib, M, Arbel, G, Gepstein, A, Yankelson, L, Aronson, D, Beyar, R, Gepstein, L. Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts. [J]. Journal of the American College of Cardiology 2007, 19(19).
[2] VAN LAAKE L W, PASSIER R, MONSHOUWER-KLOOTS J. Human embryonic stem cell-derived cardiomyocytes survive and mature in the mouse heart and transiently improve function after myocardial infarction [J]. Stem Cells and Development 2007, 1(01).
[3] Wollert KC, Meyer GP, Lotz J, Ringes Lichtenberg S, Lippolt P, Breidenbach C, Fichtner S, Korte T, Hornig B, Messinger D, Arseniev L, Hertenstein B, Ganser A, Drexler H. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. [J]. The Lancet 2004, 9429(9429).
[4] Kehat I, Khimovich L, Caspi O, Gepstein A, Shofti R, Arbel G, Huber I, Satin J, Itskovitz Eldor J, Gepstein L. Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. [J]. Nature biotechnology 2004, 10(10).
[5] Mosna F, Annunziato F, Pizzolo G, Krampera M. [J]. Cardiovascular & hematological agents in medicinal chemistry 2010.
[6] Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors [J]. Cell 2006, 4(4).
[7] 常清, 洪明, CHANG Qing, HONG Ming. iPS在临床应用的新进展 [J]. 现代生物医学进展 2009.
[8] 陈凌懿, 刘林. 诱导性多潜能干细胞（iPS）的研究现状和展望 [J]. 2009.
[9] Hilfiker A, Kasper C, Hass R, Haverich A. Mesenchymal stem cells and progenitor cells in connective tissue engineering and regenerative medicine: is there a future for transplantation? [J]. Langenbeck's archives of surgery 2011, 4(4).
[10] So KH, Han YJ, Park HY, Kim JG, Sung DJ, Bae YM, Yang BC, Park SB, Chang SK, Kim EY, Park SP. [J]. International Journal of Cardiology 2011.
[11] Mauritz C, Schwanke K, Reppel M, Neef S, Katsirntaki K, Maier LS, Nguemo F, Menke S, Haustein M, Hescheler J, Hasenfuss G, Martin U. Generation of functional murine cardiac myocytes from induced pluripotent stem cells. [J]. Circulation: An Official Journal of the American Heart Association 2008, 5(5).
[12] Germanguz, I., Sedan, O., Zeevi-Levin, N., Shtrichman, R., Barak, E., Ziskind, A., Eliyahu, S., Meiry, G., Amit, M., Itskovitz-Eldor, J., Binah, O.. Molecular characterization and functional properties of cardiomyocytes derived from human inducible pluripotent stem cells [J]. Journal of cellular and molecular medicine 2011, 1(1).
[13] van Laake LW, Qian L, Cheng P, Huang Y, Hsiao EC, Conklin BR, Srivastava D. [J]. Circulation research 2010.
[14] CHAN S S, LI Huijing, HSUEH Y H. Fibroblast growth factor-10 promotes cardiomyocyte differentiation from embryonic and induced pluripotent stem cells [J]. PLoS One 2010, 5(12).
[15] Ren Y, Lee MY, Schliffke S, Paavola J, Amos PJ, Ge X, Ye M, Zhu S, Senyei G, Lum L, Ehrlich BE, Qyang Y. [J]. Journal of Molecular and Cellular Cardiology 2011.
[16] Johnston PV, Sasano T, Mills K, Evers R, Lee ST, Smith RR, Lardo AC, Lai S, Steenbergen C, Gerstenblith G, Lange R, Marban E. Engraftment, differentiation, and functional benefits of autologous cardiosphere-derived cells in porcine ischemic cardiomyopathy. [J]. Circulation 2009, 12(12).
[17] Shimizu T, Sekine H, Yamato M. Cell sheet-based myocardial tissue engineering: new hope for damaged heart rescue. [J]. Current pharmaceutical design 2009, 24(24).
[18] Nelson TJ, Martinez Fernandez A, Yamada S. Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells. [J]. Circulation 2009, 5(5).
[19] ZHANG Jianhua, WILSON G F, SOERENS A G. Functional cardiomyocytes derived from human induced pluripotent stem cells [J]. Circulation Research 2009, 104(04).
[20] Singla DK, Long X, Glass C, Singla RD, Yan B. Induced pluripotent stem (iPS) cells repair and regenerate infarcted myocardium. [J]. Molecular pharmaceutics 2011, 5(5).
[21] YAN B, ABDELLI L S, SINGLA D K. Transplanted induced pluripotent stem cells improve cardiac function and induces neovascularization in the infarcted hearts of db/db mice [J]. Molecular Pharmacology 2011, 8(05).
[22] Gonzales C, Pedrazzini T. Progenitor cell therapy for heart disease. [Review] [86 refs] [J]. Experimental Cell Research 2009, 18(18).

诱导性多潜能干细胞在心肌再生方面的潜在应用

The potential applications of iPS cells in repairing and regenerating infarcted myocardium

PDF (PC)

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 4

编辑推荐

Metrics

本文评价

[1]	周雪,李贲,李志红,郭淑芹,张文娟. 利拉鲁肽对缺氧/复氧条件下乳鼠心肌细胞PI3K途径信号通路的作用[J]. 医学研究与教育, 2018, 35(6): 24-29.
[2]	王海洋,冯浩楼,崔玉英,范新发. 抗心肌缺血中药的研究进展[J]. 医学研究与教育, 2011, 28(3): 78-80,88.
[3]	赵文萍,刘刚,张增祥,郑晔,刘超,刘坤申,尹博英. 螺内酯等药物长时间干预对大鼠心肌损伤坏死后心肌重构的影响[J]. 医学研究与教育, 2009, 26(6): 4-7,14.
[4]	赵文萍,张增祥,刘刚,刘超,刘坤申. 螺内酯联合ACE抑制剂等药物长时问干预对大鼠心肌损伤后凋亡及其超微结构的影响[J]. 医学研究与教育, 2009, 26(1): 1-4.